Prudential Financial Upped Its Stake in Akorn (AKRX) as Share Price Declined; Css Increased Its ... .

Rheumatology

11 Views

        

Horizon Pharma plc (NASDAQ:HZNP) Logo

Css Llc increased its stake in Horizon Pharma Plc (Put) (HZNP) by 280% based on its latest 2018Q4 regulatory filing with the SEC. Css Llc bought 28,000 shares as the company’s stock rose 36.97% with the market. The institutional investor held 38,000 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $742,000, up from 10,000 at the end of the previous reported quarter. Css Llc who had been investing in Horizon Pharma Plc (Put) for a number of months, seems to be bullish on the $4.70 billion market cap company. The stock increased 1.52% or $0.42 during the last trading session, reaching $27.73. About 1.64M shares traded. Horizon Pharma plc (NASDAQ:HZNP) has risen 89.51% since March 15, 2018 and is uptrending. It has outperformed by 85.14% the S&P500. Some Historical HZNP News: 03/05/2018 – AGC BIOLOGICS, HORIZON PHARMA IN COMMERCIAL MANUFACTURING PACT; 09/05/2018 – Horizon Pharma Raises 2018 View To Sales $1.17B-$1.20B; 09/05/2018 – HORIZON PHARMA 1Q ADJ EPS 3C, EST. 6C; 09/05/2018 – Horizon Pharma plc Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth; Increases Full-Year 2018 Guidanc; 11/04/2018 – New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologi; 08/05/2018 – HORIZON PHARMA PLC – ANNOUNCES U.S. PATENT AND TRADEMARK OFFICE ISSUANCE OF ADDITIONAL NOTICES OF ALLOWANCE WITH CLAIMS COVERING RAVICTI ORAL LIQUID; 09/05/2018 – HORIZON PHARMA PLC – SEES 2018 ADJ EBITDA GUIDANCE RANGE TO $390 MLN TO $415 MLN; 03/05/2018 – AGC BIOLOGICS SAYS ENTERS INTO COMMERCIAL MANUFACTURING AGREEMENT WITH HORIZON PHARMA PLC FOR COMMERCIAL SUPPLY OF TEPROTUMUMAB; 01/05/2018 – Horizon Pharma plc to Participate in the UBS Global Healthcare Conference; 17/04/2018 – Depomed Announces the Appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate Communications

Prudential Financial Inc increased its stake in Akorn Inc (AKRX) by 436.62% based on its latest 2018Q4 regulatory filing with the SEC. Prudential Financial Inc bought 280,466 shares as the company’s stock declined 43.14% while stock markets rallied. The institutional investor held 344,701 shares of the health care company at the end of 2018Q4, valued at $1.17M, up from 64,235 at the end of the previous reported quarter. Prudential Financial Inc who had been investing in Akorn Inc for a number of months, seems to be bullish on the $430.11 million market cap company. The stock decreased 6.68% or $0.245 during the last trading session, reaching $3.425. About 2.11 million shares traded. Akorn, Inc. (NASDAQ:AKRX) has declined 77.69% since March 15, 2018 and is downtrending. It has underperformed by 82.06% the S&P500. Some Historical AKRX News: 15/05/2018 – Oxford Asset Management Buys New 1.3% Position in Akorn; 16/03/2018 – DEEP ECO: Akorn May Benefit, Industry Production Up This Quarter; 23/04/2018 – Fresenius Said Sunday That It Was Ending Deal to Buy Akorn; 18/05/2018 – FRESENIUS FREG.DE CEO SAYS COSTS RELATED TO AKORN TRANSACTION TOTAL 60 MLN EUROS SO FAR; 23/04/2018 – FRESENIUS SE AKORN, SUES FRESENIUS FOR CONSUMMATION OF MERGER; 22/04/2018 – $AKRX Fresenius terminates merger agreement with Akorn due to Akorn’s failure to fulfill several closing conditions, including material breaches of FDA data integrity requirements; 08/05/2018 – STAT Plus: As Fresenius accuses Akorn of ‘blatant fraud,’ FDA cites complaints of ‘black gunk’ in Akorn products; 23/04/2018 – FRESENIUS BELIEVES AKORN SUIT WITHOUT FOUNDATION; 23/04/2018 – Fresenius/Akorn: hard copy; 03/05/2018 – FRESENIUS SE FREG.DE SAYS EXPANSION IN NORTH AMERICA WILL TAKE LONGER WITHOUT AKORN

More notable recent Akorn, Inc. (NASDAQ:AKRX) news were published by: Globenewswire.com which released: “Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers – AKRX – GlobeNewswire” on March 01, 2019, also Globenewswire.com with their article: “Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against and Lead Deadline: April 22, 2019 – GlobeNewswire” published on March 15, 2019, Fool.com published: “Akorn (AKRX) Q4 2018 Earnings Conference Call Transcript – The Motley Fool” on February 28, 2019. More interesting news about Akorn, Inc. (NASDAQ:AKRX) were released by: Seekingalpha.com and their article: “Akorn Q4 2018 Earnings Preview – Seeking Alpha” published on February 27, 2019 as well as Seekingalpha.com‘s news article titled: “Akorn down 3% premarket on FDA inspection citations – Seeking Alpha” with publication date: February 28, 2019.

Prudential Financial Inc, which manages about $56.94 billion US Long portfolio, decreased its stake in Trinity Inds Inc (NYSE:TRN) by 291,845 shares to 570,949 shares, valued at $11.76 million in 2018Q4, according to the filing. It also reduced its holding in Clorox Co Del (NYSE:CLX) by 3,740 shares in the quarter, leaving it with 152,261 shares, and cut its stake in Microchip Technology Inc (NASDAQ:MCHP).

More notable recent Horizon Pharma plc (NASDAQ:HZNP) news were published by: Benzinga.com which released: “50 Stocks Moving In Friday’s Mid-Day Session – Benzinga” on March 08, 2019, also Streetinsider.com with their article: “Pre-Open Stock Movers 02/28: (SQBG) (TTOO) (WBC) Higher; (NVAX) (SYNH) (BOX) Lower (more…) – StreetInsider.com” published on February 28, 2019, Benzinga.com published: “Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis – Benzinga” on March 01, 2019. More interesting news about Horizon Pharma plc (NASDAQ:HZNP) were released by: Benzinga.com and their article: “Benzinga’s Top Upgrades, Downgrades For March 8, 2019 – Benzinga” published on March 08, 2019 as well as Benzinga.com‘s news article titled: “75 Biggest Movers From Yesterday – Benzinga” with publication date: March 01, 2019.

Investors sentiment increased to 1.33 in 2018 Q4. Its up 0.47, from 0.86 in 2018Q3. It improved, as 27 investors sold HZNP shares while 60 reduced holdings. 54 funds opened positions while 62 raised stakes. 136.51 million shares or 1.16% more from 134.96 million shares in 2018Q3 were reported. Signaturefd Ltd Com holds 0% or 46 shares in its portfolio. Knott David M has invested 0.68% in Horizon Pharma plc (NASDAQ:HZNP). Pnc Services Grp has 3,109 shares. Envestnet Asset Management holds 0% or 74,207 shares in its portfolio. Smith Asset Management Ltd Partnership stated it has 0.07% in Horizon Pharma plc (NASDAQ:HZNP). Caprock Grp Inc has invested 0.06% in Horizon Pharma plc (NASDAQ:HZNP). Clarivest Asset Mngmt Llc stated it has 0.06% of its portfolio in Horizon Pharma plc (NASDAQ:HZNP). Int Group Inc reported 110,573 shares or 0.01% of all its holdings. Alyeska Invest Group LP has invested 0.01% in Horizon Pharma plc (NASDAQ:HZNP). Tudor Et Al holds 132,216 shares or 0.05% of its portfolio. Intrust Fincl Bank Na stated it has 14,658 shares or 0.08% of all its holdings. Bluemountain Cap Mngmt Ltd holds 31,684 shares. State Board Of Administration Of Florida Retirement System holds 160,045 shares. 21,800 were accumulated by Quantitative Mngmt Limited Com. Amundi Pioneer Asset holds 0% of its portfolio in Horizon Pharma plc (NASDAQ:HZNP) for 24,200 shares.

Since November 14, 2018, it had 0 insider buys, and 2 selling transactions for $9.00 million activity. $204,559 worth of stock was sold by CURTIS GEOFFREY M. on Tuesday, February 5.

Css Llc, which manages about $1.49 billion US Long portfolio, decreased its stake in Netflix Inc (NASDAQ:NFLX) by 2,258 shares to 242 shares, valued at $65,000 in 2018Q4, according to the filing. It also reduced its holding in Twitter Inc (NYSE:TWTR) by 23,100 shares in the quarter, leaving it with 26,900 shares, and cut its stake in Insulet Corp (Prn).

Akorn, Inc. (NASDAQ:AKRX) Institutional Positions Chart